ASX - Delayed Quote AUD

Neurotech International Limited (NTI.AX)

0.0900 0.0000 (0.00%)
At close: April 26 at 4:10 PM GMT+10
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
5.9590
5.9590
38.2850
206.3670
80.3410
Cost of Revenue
--
--
34.0490
-20.3400
54.8940
Gross Profit
5.9590
5.9590
4.2360
226.7070
25.4470
Operating Expense
9,055.0310
9,055.0310
3,934.9270
7,674.9300
1,316.9670
Operating Income
-9,049.0720
-9,049.0720
-3,930.6910
-7,448.2230
-1,291.5200
Net Non Operating Interest Income Expense
59.5610
59.5610
-0.8830
-1.5740
-421.9190
Other Income Expense
1,197.5720
1,197.5720
569.3330
19.1690
--
Pretax Income
-7,791.9390
-7,791.9390
-3,362.2410
-7,430.6280
-1,713.4390
Net Income Common Stockholders
-7,791.9390
-7,791.9390
-3,362.2410
-7,430.6280
-1,713.4390
Basic EPS
-0.01
-0.01
-0.00
-0.02
-0.01
Diluted EPS
-0.01
-0.01
-0.00
-0.02
-0.01
Basic Average Shares
798,771.9720
798,771.9720
697,272.5070
492,617.8080
154,570.8800
Diluted Average Shares
798,771.9720
798,771.9720
697,272.5070
492,617.8080
154,570.8800
Net Income from Continuing & Discontinued Operation
-7,791.9390
-7,791.9390
-3,362.2410
-7,430.6280
-1,713.4390
Normalized Income
-7,791.9390
-7,791.9390
-3,362.2410
-7,449.7980
-1,713.4390
Interest Income
59.5610
59.5610
0.4860
0.1350
1.7550
Interest Expense
--
--
1.3690
1.7090
421.2450
Net Interest Income
59.5610
59.5610
-0.8830
-1.5740
-421.9190
EBIT
-9,049.0720
-9,049.0720
-3,360.8720
-7,428.9190
-1,292.1940
EBITDA
-9,047.3280
-9,047.3280
-3,360.2840
-7,428.9190
-1,211.1120
Reconciled Cost of Revenue
--
--
34.0490
-20.3400
54.8940
Reconciled Depreciation
1.7440
1.7440
0.5880
--
81.0820
Net Income from Continuing Operation Net Minority Interest
-7,791.9390
-7,791.9390
-3,362.2410
-7,430.6280
-1,713.4390
Total Unusual Items Excluding Goodwill
--
--
--
19.1700
--
Total Unusual Items
--
--
--
19.1700
--
Normalized EBITDA
-9,047.3280
-9,047.3280
-3,360.2840
-7,448.0890
-1,211.1120
6/30/2020 - 11/3/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CBL.AX Control Bionics Limited
0.0430
0.00%
 
CYC.AX Cyclopharm Limited
1.7500
0.00%
 
UCM.AX Uscom Limited
0.0310
0.00%
 
LBT.AX LBT Innovations Limited
0.0200
+5.26%
 
RSH.AX Respiri Limited
0.0340
+3.03%
 
CMP.AX Compumedics Limited
0.2500
-3.85%
 
IRX.AX InhaleRx Limited
0.0280
0.00%
 
CSX.AX CleanSpace Holdings Limited
0.3300
0.00%
 
HMD.AX HeraMED Limited
0.0170
0.00%
 
CDX.AX CardieX Limited
0.0590
-6.35%